CYTK
Cytokinetics Inc
Price:  
50.70 
USD
Volume:  
626,927.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CYTK WACC - Weighted Average Cost of Capital

The WACC of Cytokinetics Inc (CYTK) is 8.6%.

The Cost of Equity of Cytokinetics Inc (CYTK) is 9.00%.
The Cost of Debt of Cytokinetics Inc (CYTK) is 6.80%.

Range Selected
Cost of equity 7.00% - 11.00% 9.00%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 6.60% - 7.00% 6.80%
WACC 6.8% - 10.4% 8.6%
WACC

CYTK WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.67 1.09
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.00% 11.00%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.1 0.1
Cost of debt 6.60% 7.00%
After-tax WACC 6.8% 10.4%
Selected WACC 8.6%